The APERLURI brand, founded in 2009 (United States), from 5 sister brands and 2214 competing brands. APERLURI is owned by PTC Therapeutics, listed on the stock exchange of New York APERLURI belongs to the Biotechnology business sector.

APERLURI is a brand of PTC Therapeutics (PTCT) Share price

Share price and profitability of the share PTC Therapeutics (APERLURI)

Buy PTC Therapeutics share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.

Investment simulator :

Amount invested USD 29.07

Portfolio valuation
PTC Therapeutics (APERLURI) over 5 years* USD 22.23

Stock market history PTC Therapeutics (APERLURI)

Desirable brands that generate Pricing Power and therefore stock market performance

Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.

Read more